Molina Healthcare Inc 2024年度报告

Form 10-K (Mark One) ☐ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIESEXCHANGE ACT OF 1934FOR THE FISCAL YEAR ENDED DECEMBER 31, 2024or ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIESEXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ________ TO________ Commission File Number 1-31719 MOLINA HEALTHCARE, INC.(Exact name of registrant as specified in its charter) 13-4204626 (State or other jurisdiction ofincorporation or organization) (I.R.S. Employer 200 Oceangate, Suite 100, Long Beach, California 90802(Address of principal executive offices) (Zip Code) (562) 435-3666(Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Title of Each ClassCommon Stock, $0.001 Par Value Trading Symbol(s)MOH Name of Each Exchange on Which Registered New York Stock Exchange Securities registered pursuant to Section 12(g) of the Act: Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of theSecurities Act.☐Yes☐No Indicateby check mark if the registrant is not required to file reports pursuant to Section 13 orSection 15(d) of the Act.☐Yes☐No Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter periodthat the registrant was required to file such reports), and (2) has been subject to such filing requirementsfor the past 90 days.☐Yes☐No Indicate by check mark whether the registrant has submitted electronically every Interactive Data Filerequired to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during thepreceding 12 months (or for such shorter period that the registrant was required to submit such files).☐Yes☐No Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of“large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company”in Rule 12b-2 of the Exchange Act. Large accelerated filer☐Accelerated filer☐Non-accelerated filer☐Smaller reporting company☐Emerginggrowthcompany☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use theextended transition period for complying with any new or revised financial accounting standards providedpursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant has filed a report on and attestation to its management’sassessment of the effectiveness of its internal control over financial reporting under Section 404(b) of theSarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issuedits audit report.☐ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether thefinancial statements of the registrant included in the filing reflect the correction of an error to previouslyissued financial statements.☐ Indicate by check mark whether any of those error corrections are restatements that required a recoveryanalysis of incentive-based compensation received by any of the registrant’s executive officers during therelevant recovery period pursuant to §240.10D-1(b).☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of theAct).☐Yes☐No The aggregate market value of Common Stock held by non-affiliates of the registrant as of June 30, 2024,the last business day of our most recently completed second fiscal quarter, was approximately $17.2billion (based upon the closing price for shares of the registrant’s Common Stock as reported by the NewYork Stock Exchange, Inc. on June 30, 2024). As of February 7, 2025, approximately 55.5 million shares of the registrant’s Common Stock, $0.001 parvalue per share, were outstanding. Portionsof the registrant’s Proxy Statement for the 2025 Annual Meeting of Stockholders areincorporated by reference into Part III of this Annual Report on Form 10-K, to the extent describedtherein. MOLINA HEALTHCARE, INC. 2024 FORM 10-K TABLE OF CONTENTS Page Part I Item Number 1.Business1A.Risk Factors1B.Unresolved Staff Comments1C.Cybersecurity2.Properties3.Legal Proceedings4.Mine Safety Disclosures Part II 5.Market for Registrant’s Common Equity, Related Stockholder Matters and IssuerPurchases of Equity Securities376.[Reserved]Not Applicable.7.Management’s Discussion and Analysis of Financial Condition and Results of Operations397A.Quantitative and Qualitative Disclosures About Market Risk518.Financial Statements and Supplementary Data529.Changes in and Disagreements with Accountants on Accounting and FinancialDisclosureNot Applicable.9A.Controls and Procedures909B.Other Information939C.Disclosure Regarding Foreign Jurisdictions that Prevent InspectionsNot App